Anzemet
Active Ingredient(s): DolasetronFDA Approved: * September 11, 1997
Pharm Company: * SANOFI AVENTIS US
Category: Nausea & Vomiting
Dolasetron (trade name Anzemet) is a serotonin 5-HT3 receptor antagonist used to treat nausea and vomiting following chemotherapy.[1] Its main effect is to reduce the activity of the vagus nerve, which is a nerve that activates the vomiting center in the medulla oblongata. It does not have much antiemetic effect when symptoms are due to motion sickness. This drug does not have any effect on dopamine receptors or muscarinic receptors. Dolasetron breaks down slowly, staying in t... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.4 Discussions